Sensyne Health, the Oxford-based clinical AI company, has launched the first operational AI algorithm developed on its SENSE algorithm engine, a cloud-based platform to support real-time operational and clinical patient management across multiple medical conditions.
SYNE-OPS-1 provides an hourly risk forecast of the expected number of future ICU admissions and the future demand for ventilators, based on an analysis of clinical data on COVID patients being admitted to hospital. This enables hospital managers to direct resources across the hospital more effectively in the face of changing numbers of patient admissions amid the pandemic.
The algorithm uses anonymised clinical data on patients with COVID such as vital signs and laboratory test results transmitted to the SENSE clinical AI platform. These data are then analysed and the results presented via a dashboard to help hospital managers make informed decisions about the need for hospital resources.
SYNE-OPS-1 is now integrated into the operational workflow at Chelsea and Westminster Hospital NHS Foundation Trust to help the Trust predict ICU capacity needs for patients with COVID.
Roger Chinn, Chief Medical Officer and Chief Clinical Information Officer at Chelsea & Westminster Hospital NHS Foundation Trust said: “The SYNE-OPS-1 algorithm has proved invaluable during this current wave of the pandemic. We are able to predict ventilator and non-mechanical support requirements in ICU, helping us to make best use of our expertise and resources. In collaboration with Sensyne Health and as part of our CW Innovation programme, we are embracing digital innovation, data integration, and analytics to support and improve clinical decision making and practice.”
SYNE-OPS-1 is the first in a number of operational algorithms expected to be developed by Sensyne using the SENSE platform. It is now being marketed to other hospitals in the UK and USA.
Sensyne CEO Lord (Paul) Drayson said: “The successful deployment of our first operational algorithm, developed in collaboration with our research partners at Chelsea and Westminster NHS Foundation Trust, is an important milestone for Sensyne. We aim to build a broad range of operational algorithms on our SENSE platform to help significantly improve the performance of health systems with the potential of generating a significant commercial return for Sensyne and our research partners.”